Role of specialty care for chronic diseases: A report from an ad hoc committee of the american college of rheumatology

Mayo Clinic Proceedings

Volumn 71, Issue 12, 1996, Pages 1179-1181

  Gabriel, S E ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC APPROACH ROUTE; MANAGED CARE; MEDICAL SPECIALIST; PATIENT REFERRAL; PRIMARY MEDICAL CARE; REVIEW; RHEUMATIC DISEASE; RHEUMATOLOGY;

EID: 0030317255     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/71.12.1179     Document Type: Article

References (28)

1. Holman HR. Thought barriers to understanding rheumatic diseases. Arthritis Rheum 1994; 37:1565-1572
2. Centers for Disease Control. Arthritis prevalence and activity limitations-United States, 1990. MMWR Morb Mortal Wkly Rep 1994; 43:433-438
3. Goldenberg DL, Mason JH, De Horatius R, Goldberg V, Kaplan SR, Keiser H, et al. Rheumatology education in United States medical school. Arthritis Rheum 1981; 24:1561-1566
4. Bellamy N, Gilbert JR, Brooks PM, Emmerson BT, Campbell J. A survey of current prescribing practices of antiinflammatory and urate lowering drugs in gouty arthritis in the province of Ontario. J Rheumatol 1988; 15:1841-1847
5. Chan KW, Felson DT, Yood RA, Walker AM. The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis Rheum 1994; 37:814-820
6. Panush RS, Carias K, Kramer N, Rosenstein ED. Acute arthritis in the hospital: comparison of rheumatologic with non-rheumatologic care. J Clin Rheumatol 1995; 1:74-80
7. Hasselbacher P. Variation in synovial fluid analysis by hospital laboratories. Arthritis Rheum 1987; 30:637-642
8. Ward MM, Leigh JP, Fries JF. Progression of functional disability in patients with rheumatoid arthritis: associations with rheumatology subspecialty care. Arch Intern Med 1993; 153:2229-2237
9. EsdaileJM, Joseph L, MacKenzieT, Kashgarian M, HayslettJP. The benefit of early treatment with immunosuppressive agents in lupus nephritis. J Rheumatol 1994; 21:2046-2051
10. Mclnnes PM, Schuttinga J, Sanslone WR, Stark SP, Klippel JH. The economic impact of treatment of severe lupus nephritis with pred-nisone and intravenous cyclophosphamide. Arthritis Rheum 1994; 37:1000-1006
11. Fafalak RG, Peterson MG, Kagen LJ. Strength in polymyositis and dermatomyositis: best outcome in patients treated early. J Rheumatol 1994; 21:643-648
12. Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, et al. A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. NEnglJMed 1974; 291:932-934
13. Lopez-Ovejero JA, Saal SD, D'Angelo WA, Cheigh JS, Stenzel KH, Laragh JH. Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade. NEnglJMed 1979; 300:1417-1419
14. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116:488-498
15. Cohen RD, Conn DL, Ilstrup DM. Clinical features, prognosis, and response to treatment in polyarteritis. Mayo Clin Proc 1980; 55:146155
16. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. NEnglJMed 1991; 324:1633-1639
17. Ahlmen M, Sullivan M, Bjelle A. Team versus non-team outpatient care in rheumatoid arthritis: a comprehensive outcome evaluation including an overall health measure. Arthritis Rheum 1988; 31:471479
18. Clarke AE, Esdaile JM, Hawkins D. Inpatient rheumatic disease units: are they worth it? [editorial]. Arthritis Rheum 1993;36:13371340
19. Duff IF, Carpenter JO, Neukom JE. Comprehensive management of patients with rheumatoid arthritis: some results of the regional Arthritis Control Program in Michigan. Arthritis Rheum 1974; 17:635-645
20. Helewa A, Bombardier C, Goldsmith CH, Menchions B, Smythe HA. Cost-effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 1989; 32:1505-1514
21. Katz S, Vignos PJ Jr, Moskowitz RW, Thompson HM, Svec KH. Comprehensive outpatient care in rheumatoid arthritis: a controlled study. JAMA 1968; 206:1249-1254
22. Kraag G, Stokes B, Groh J, Helewa A, Goldsmith C. The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis-a randomized controlled trial. J Rheumatol 1990; 17:228-233
23. Spiegel JS, Spiegel TM, Ward NB, Paulus HE, Leake B, Kane RL. Rehabilitation for rheumatoid arthritis patients: a controlled trial. Arthritis Rheum 1986; 29:628-637
24. Kovar PA, Allegrante JP, MacKenzie CR, Peterson MG, Gutin B, Charlson ME. Supervised fitness walking in patients with osteoarthritis of the knee: a randomized, controlled trial. Ann Intern Med 1992; 116:529-534
25. Kraag G, Stokes B, Groh J, Helewa A, Goldsmith CH. The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis-an 8-month followup. J Rheumatol 1994; 21:261-263
26. Robb-Nicholson LC, Daltroy L, Eaton H, Gall V, Wright E, Hartley LH, et al. Effects of aerobic conditioning in lupus fatigue: a pilot study. BrJ Rheumatol 1989; 28:500-505
27. Lorig KR, Mazonson PD, Holman HR. Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs. Arthritis Rheum 1993; 36:439-446
28. Clement DG, Retchin SM, Brown RS, Stegall MH. Access and outcomes of elderly patients enrolled in managed care. JAMA 1994; 271:1487-1492